Correlation Between Okta and XSpray Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Okta and XSpray Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and XSpray Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and XSpray Pharma AB, you can compare the effects of market volatilities on Okta and XSpray Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of XSpray Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and XSpray Pharma.

Diversification Opportunities for Okta and XSpray Pharma

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Okta and XSpray is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and XSpray Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XSpray Pharma AB and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with XSpray Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XSpray Pharma AB has no effect on the direction of Okta i.e., Okta and XSpray Pharma go up and down completely randomly.

Pair Corralation between Okta and XSpray Pharma

Given the investment horizon of 90 days Okta Inc is expected to under-perform the XSpray Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Okta Inc is 1.93 times less risky than XSpray Pharma. The stock trades about -0.08 of its potential returns per unit of risk. The XSpray Pharma AB is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  3,970  in XSpray Pharma AB on August 29, 2024 and sell it today you would earn a total of  225.00  from holding XSpray Pharma AB or generate 5.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.47%
ValuesDaily Returns

Okta Inc  vs.  XSpray Pharma AB

 Performance 
       Timeline  
Okta Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Okta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Okta is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
XSpray Pharma AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XSpray Pharma AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Okta and XSpray Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Okta and XSpray Pharma

The main advantage of trading using opposite Okta and XSpray Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, XSpray Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XSpray Pharma will offset losses from the drop in XSpray Pharma's long position.
The idea behind Okta Inc and XSpray Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm